Cas:3589-73-9 6-Methoxyharmalan manufacturer & supplier

Chemical Name:6-Methoxyharmalan

CAS.NO:3589-73-9

Synonyms:2-methoxyharmalane;6-Methoxyharmalane;6-Methoxy-1-methyl-4,9-dihydro-3H-pyrido(3,4-b)indole monohydrochloride;4,9-Dihydro-6-methoxy-1-methyl-3H-pyrido<3,4-b>indole;MFCD00055938;6-Methoxyharmalan;3H-Pyrido(3,4-b)indole,4,9-dihydro-6-methoxy-1-methyl-,monohydrochloride;10-Methoxyharmalan;Methoxy-6-harmalan

Molecular Formula:C₁₃H₁₄N₂O

Molecular Weight:214.26300

HS Code:2933990090

Physical and Chemical Properties:

Melting point:208 – 209ºC

Boiling point:417.7ºC at 760mmHg

Density:1.25g/cm3

Index of Refraction:1.647

PSA:37.38000

Exact Mass:214.11100

LogP:1.97720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 2-methoxyharmalane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methoxy-6-harmalan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methoxyharmalane Use and application,indole technical grade,usp/ep/jp grade.

Related News: Any US citizen who has been in the Hubei province in the last 14 days will be subject to up to 14 days of mandatory quarantine upon return to the United States. 6-Methoxyharmalan manufacturer The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development. 6-Methoxyharmalan supplier Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries. 6-Methoxyharmalan vendor Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 6-Methoxyharmalan factory Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.